PGT-A may overestimate impact of embryo abnormalities
A common IVF 'add-on' – preimplantation genetic testing for aneuploidy (PGT-A) – may overestimate the impact of embryo abnormalities, new research suggests...
A common IVF 'add-on' – preimplantation genetic testing for aneuploidy (PGT-A) – may overestimate the impact of embryo abnormalities, new research suggests...
A gene variant that can cause inaccurate type 2 diabetes blood test results is more prevalent in black and South Asian men, and can delay diagnosis...
A new mRNA-based therapy has restored fertility in mice that were unable to produce sperm...
Widening access to cell and gene therapies could result in economic gains of over £20 billion for the UK within a decade, according to a new report...
Speakers highlighted the need for interdisciplinary dialogue between ethicists and researchers when considering ethical research involving stem cell-based-embryo models...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
Comment
Rare Disease Genomic Testing: How Do We Make Access Equitable and Timely?
by Davy Tennison
The latest event from PET brought together professionals and patient voices to explore how best to improve access to genetic and genomic testing for rare disease...
The Generation Study: changing lives and building the evidence around genomic newborn screening
by Amanda Pichini
Genomics could have a transformative impact for newborn screening, explains Amanda Pichini...
FILM: Robert Edwards at 100 – Part 2
by Professor Barry Bavister
PET presents a series of talks celebrating the 100th birthday of the late IVF pioneer Professor Sir Robert Edwards. This second talk is by Edwards' colleague, Professor Barry Bavister...